PAUL H KLINGENSTEIN Insider Trading $CLVS Clovis Oncology, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL H KLINGENSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL H KLINGENSTEIN. PAUL H KLINGENSTEIN is Director in EnteroMedics Inc ($ETRM) and Director in Anacor Pharmaceuticals, Inc. ($ANAC) and Director in Clovis Oncology, Inc. ($CLVS).
PAUL H KLINGENSTEIN in Clovis Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL H KLINGENSTEIN: Director
Holdings: 59,327 shares
Current Value: $3,559,620
Latest Transaction: Jun 11 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL H KLINGENSTEIN in Clovis Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, CLVS, RSLS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 5.97 | 42,223 | 252,071 | 42,223 | |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
| Jul 31 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | M | 0.29 | 25,862 | 7,500 | 0 | |
| Jul 31 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Buy | M | 0.29 | 25,862 | 7,500 | 59,327 | 33.5 K to 59.3 K (+77.28 %) |
| Jun 07 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
| Jun 07 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Jun 08 2017 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 59.56 | 10,000 | 595,600 | 10,000 | |
| Jun 10 2016 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 15.23 | 10,000 | 152,300 | 10,000 | |
| Jun 15 2015 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 87.15 | 10,000 | 871,500 | 10,000 |
Page: 1